The role of graft T-cell size in patients receiving alemtuzumab serotherapy for non-malignant disorders: results of an institutional protocol
Abstract Although graft T cells assist in engraftment, mediate antiviral immune-reconstitution, and cause graft-versus-host disease, graft size is not determined by T-cell content of the graft. The conventional method of graft size determination based on CD34+ cells with alemtuzumab serotherapy is a...
Main Authors: | Ambreen Pandrowala, Sanna Khan, Darshan Kataria, Manasa Kakunje, Varsha Mishra, Dhruv Mamtora, Sangeeta Mudaliar, Minnie Bodhanwala, Bharat Agarwal, Prashant Hiwarkar |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2024-01-01
|
Series: | Scientific Reports |
Online Access: | https://doi.org/10.1038/s41598-023-50416-6 |
Similar Items
-
Narsoplimab for severe transplant-associated thrombotic microangiopathy
by: Ambreen Pandrowala, et al.
Published: (2023-03-01) -
Reduced toxicity conditioning and a high CD34+ cell dose can achieve full donor chimerism in DOCK8 deficiency
by: Ambreen Pandrowala, MBBS, DNB (Paediatrics), et al.
Published: (2023-08-01) -
Antibiotic rotation to prevent multidrug resistance in pediatric oncology unit
by: Vaibhav Chadha, et al.
Published: (2022-01-01) -
Tolerance to rat monoclonal antibodies. Implications for serotherapy.
by: Benjamin, R, et al.
Published: (1986) -
Immunosuppression with monoclonal antibodies--rules for effective serotherapy.
by: Cobbold, S, et al.
Published: (1985)